Arpa Garay

Insider Reports History

Entity
Individual
Location
2000 Galloping Hill Rd, Kenilworth, NJ
Signature
/s/ James Dillon, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Arpa Garay:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Moderna, Inc. Chief Commercial Officer Restricted Stock Units 11.4K $1.14M $100.01 Dec 5, 2023 Direct
Moderna, Inc. Chief Commercial Officer Common Stock 3.69K $383K $103.90 Dec 6, 2023 Direct
Merck & Co., Inc. SVP Human Health Global Mktg. Common Stock 2.11K $252K $119.43 May 4, 2022 Direct
Merck & Co., Inc. SVP Human Health Global Mktg. Restricted Stock Unit 1.82K $234K $128.80 May 4, 2022 Direct
Merck & Co., Inc. SVP Human Health Global Mktg. Stock Option (Right to Buy) 21.4K May 3, 2022 Direct

Insider Reports Filed by Arpa Garay

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MRNA Moderna, Inc. Dec 5, 2023 3 -$44.2K 4 Dec 7, 2023 Chief Commercial Officer
MRNA Moderna, Inc. Sep 5, 2023 3 -$62.2K 4 Sep 7, 2023 Chief Commercial Officer
MRNA Moderna, Inc. Jun 5, 2023 3 -$288K 4 Jun 7, 2023 Chief Commercial Officer
MRNA Moderna, Inc. Feb 28, 2023 2 $0 4 Mar 2, 2023 Chief Commercial Officer
MRNA Moderna, Inc. Jun 28, 2022 0 $0 3 Jun 29, 2022 Chief Commercial Officer
MRK Merck & Co., Inc. May 3, 2022 4 $56.4K 4 May 5, 2022 SVP Human Health Global Mktg.
MRK Merck & Co., Inc. May 3, 2022 3 $48.4K 4 May 4, 2022 SVP Human Health Global Mktg.
MRK Merck & Co., Inc. May 1, 2022 3 $54.9K 4 May 3, 2022 SVP Human Health Global Mktg.
MRK Merck & Co., Inc. Feb 28, 2022 0 $0 3 Mar 10, 2022 SVP Human Health Global Mktg.